BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 190925)

  • 1. Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine.
    Scott FW
    Am J Vet Res; 1977 Feb; 38(2):229-34. PubMed ID: 190925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline caliciviral disease: experimental immunoprophylaxis.
    Kahn DE; Hoover EA
    Am J Vet Res; 1976 Mar; 37(3):279-83. PubMed ID: 1259224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
    Scott FW; Geissinger CM
    Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of an inactivated vaccine for the prevention of rhinotracheitis, caliciviral disease, and panleukopenia in cats.
    Povey RC; Koonse H; Hays MB
    J Am Vet Med Assoc; 1980 Aug; 177(4):347-50. PubMed ID: 6256329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of an intranasal combined feline viral rhinotracheitis, feline calicivirus vaccine and the FVR carrier state.
    Orr CM; Gaskell CJ; Gaskell RM
    Vet Rec; 1980 Feb; 106(8):164-6. PubMed ID: 6244692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of a combined feline viral rhinotracheitis-feline calicivirus vaccine and the FVR carrier state.
    Orr CM; Gaskell CJ; Gaskell RM
    Vet Rec; 1978 Sep; 103(10):200-2. PubMed ID: 212859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an inactivated feline calicivirus (FCV) vaccine against challenge with United Kingdom field strains and its interaction with the FCV carrier state.
    Gaskell CJ; Gaskell RM; Dennis PE; Wooldridge MJ
    Res Vet Sci; 1982 Jan; 32(1):23-6. PubMed ID: 6283611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against feline calicivirus infection.
    Bittle JL; Rubic WJ
    Am J Vet Res; 1976 Mar; 37(3):275-8. PubMed ID: 1259223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
    Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against feline viral rhinotracheitis in kittens with maternally derived feline viral rhinotracheitis antibodies.
    Johnson RP; Povey RC
    J Am Vet Med Assoc; 1985 Jan; 186(2):149-52. PubMed ID: 2982774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1.
    Lappin MR; Sebring RW; Porter M; Radecki SJ; Veir J
    J Feline Med Surg; 2006 Jun; 8(3):158-63. PubMed ID: 16442823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the safety and efficacy of an intranasal feline rhinotracheitis-calici virus vaccine.
    Davis EV; Beckenhauer WH
    Vet Med Small Anim Clin; 1976 Oct; 71(10):1405-10. PubMed ID: 185775
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response to an inactivated vaccine for rhinotracheitis, caliciviral disease, and panleukopenia in nondomestic felids.
    Bush M; Povey RC; Koonse H
    J Am Vet Med Assoc; 1981 Dec; 179(11):1203-5. PubMed ID: 6276346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of two commercial feline rhinotracheitis-calicivirus-panleukopenia vaccines.
    Povey RC
    Can Vet J; 1979 Oct; 20(10):253-60. PubMed ID: 232426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines.
    Lappin MR; Veir J; Hawley J
    J Feline Med Surg; 2009 Feb; 11(2):159-62. PubMed ID: 18782676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic and protective effects of the F-2 strain of feline viral rhinotracheitis virus.
    Bittle JL; Rubic WJ
    Am J Vet Res; 1975 Jan; 36(1):89-91. PubMed ID: 163604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.
    Rong S; Lowery D; Floyd-Hawkins K; King V
    Virus Res; 2014 Aug; 188():60-7. PubMed ID: 24685673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens.
    Kanellos T; Sutton DJ; Salisbury CF; Chalmers WS
    J Feline Med Surg; 2008 Aug; 10(4):346-54. PubMed ID: 18448375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease.
    Huang C; Hess J; Gill M; Hustead D
    J Feline Med Surg; 2010 Feb; 12(2):129-37. PubMed ID: 19836282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.